Upregulation of Fas/Fas ligand in inclusion body myositis

Annals of Neurology

Volumn 43, Issue 1, 1998, Pages 127-130

  Fyhr, Ing Marie ^a   Oldfors, Anders ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENERVATION; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; MONONUCLEAR CELL; POLYMYOSITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANTIGENS, CD95; FAS LIGAND PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MUSCLES; MUSCULAR DISEASES; MYOSITIS, INCLUSION BODY; POLYMERASE CHAIN REACTION; POLYMYOSITIS; REFERENCE VALUES; RNA, MESSENGER; STAINING AND LABELING; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0031939972     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430123     Document Type: Article

References (20)

1. Askanas V, Engel WK. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myositis. Curr Opin Rheumatol 1995;7:486
2. Arahata K, Engel A. Monoclonal antibody analysis of mononuclear cells in myopathies. V. Identification and quantification of T8+ cytotoxic and T8+ suppressor cells. Ann Neurol 1988;23:493
3. Berke G. The CTL's kiss of death. Cell 1995;81:9
4. Lowin B, Mattman C, Hahne M, Tschopp J. Comparison of Fas (APO-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol 1996;8:57
5. Itoh N, Yonehara S, Ishii A, et al. The polypepetide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233
6. Mita E, Hayashi N, Iio S, et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994;204:468
7. Watanabe-Fukunaga R, Brannan C, Copeland N, et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314
8. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705
9. Goebels N, Michaelis D, Engelhardt M, et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996;97:2905
10. Schneider C, Gold R, Dalakas M, et al. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory cells: Studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol 1996;55:1205
11. Yamada H, Nakagawa M, Higuchi I, et al. Type II muscle fibers are stained by anti-Fas antibody. J Neurol Sci 1995;134:115
12. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449
13. Asahara H, Hasumuna T, Kobata T, et al. Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. Clin Immunol Immunopathol 1996;81:27
14. Watanabe-Fukunaga R, Brannan C, Itoh N, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274
15. Smith J, Fowkws G, Schofield P. Programmed cell death in dystrophic (mdx) muscle is inhibited by IGF-II. Cell Death Differ 1995;243
16. Tews D, Goebel H. DNA-fragmentatton and bcl-2 expression in infantile spinal muscular atrophy. Ncuromusc Disord 1996;6:265
17. Tews D, Goebel H. Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J Neuropath Exp Neurol 1997;56:150
18. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456
19. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and auto-immunity. Science 1995;268:1347
20. Mountz J, Wu J, Cheng J, Zhou T. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994;37:1415